SCHEMBL6828378

SCHEMBL6828378

CC(C)(C)OC(=O)NCCN1CCCC1C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.45
CACNA1H O95180 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
DRD2 P14416 4/20 0.40
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
HRH3 Q9Y5N1 2/20 0.37
SIRT2 Q8IXJ6 1/20 0.37
SIRT1 Q96EB6 1/20 0.37
SIRT3 Q9NTG7 1/20 0.37
ACHE P22303 1/20 0.36
BACE1 P56817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7131093 1.00 EPHX1 (0.45) EPHX1CACNA1HMAOAMAOBDRD2
SCHEMBL7345920 0.91 MAOA (0.47) EPHX1MAOAMAOBDRD2TDP1
SCHEMBL29552567 0.89 ACHE (0.47) EPHX1MAOAMAOBDRD2TDP1
SCHEMBL18851364 0.88 EPHX1 (0.46) EPHX1CACNA1HDRD2TDP1MEN1
SCHEMBL20545129 0.88 EPHX1 (0.46) EPHX1CACNA1HDRD2TDP1MEN1
SCHEMBL18851365 0.88 EPHX1 (0.46) EPHX1CACNA1HDRD2TDP1MEN1
SCHEMBL22151747 0.87 EPHX1 (0.45) EPHX1CACNA1HDRD2TDP1MEN1
SCHEMBL337969 0.87 EPHX1 (0.45) EPHX1CACNA1HDRD2TDP1MEN1
SCHEMBL22151806 0.84 ALDH1A1 (0.51) EPHX1CACNA1HDRD2MEN1KMT2A
SCHEMBL3266228 0.83 EPHX1 (0.43) EPHX1MAOAMAOBDRD2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069829-A1 (2S)-2-((PYRIMIDIN-4-YL)AMINO)-4-METHYLPENTANOIC ACID AMINOETHYLAMID DERIVATIVES AS IL-8 RECEPTOR MODULATORS FOR THE TREATMENT OF ATHEROSCLEROSIS AND RHEUMATOID ARTHRITIS PHARMACOPEIA DRUG DISCOVERY, INC. (US) 2004-08-19 WO disclosed